Serum sCD40L and galectin-3 in the prognosis prediction of patients with acute ischemic stroke. (PubMed, J Med Biochem) - Sep 25, 2026 - "All patients received emergencytreatment with tenecteplase (TNK-tPA) combined withXuesaitong...For predicting poor prognosis, serum galectin-3 and scd40ldemonstrated AUCs of 0.774 and 0.838, respectively; theirspecificities were 67.58% and 75.36% , respectively, whiletheir sensitivities were 75.06% and 80.04% , respectively.The combined prediction of serum galectin-3 and scd40lfor poor prognosis was less effective, with an AUC of 0.919,a specificity of 60.05%, and a sensitivity of 90.63%. Both sCD40L and serum galectin-3 levelshave some prognostic value for poor prognosis and ineffective treatment in AIS patients, and combining their detection can significantly improve predictive efficacy."
Journal • Cardiovascular • Ischemic stroke • CD40LG • LGALS3
|
|
Fan Zhaoyang; Kunqing Luo; Lin Shuping; Quanhua Xiao; Xianliang Lai; Zhiqin Chen
|